Gr1-/low CD11b-/low MHCII+ myeloid cells boost T cell anti-tumor efficacy.
Payne KK, Aqbi HF, Butler SE, Graham L, Keim RC, Wan W, Idowu MO, Bear HD, Wang XY, Manjili MH.
Payne KK, et al. Among authors: wan w.
J Leukoc Biol. 2018 Dec;104(6):1215-1228. doi: 10.1002/JLB.5A0717-276RR. Epub 2018 Jul 9.
J Leukoc Biol. 2018.
PMID: 29985529
Free PMC article.